Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer
Tools
Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S.
(2014)
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer.
EUROPEAN JOURNAL OF CANCER, 50 (5).
pp. 1042-1043.
ISSN 0959-8049
Full text not available from this repository.
Item Type: | Letter |
---|---|
Authors (ICR Faculty only): | De Bono, Johann |
All Authors: | Lorente, D., Bianchini, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., De Bono, J. S. |
Additional Information: | ISI Document Delivery No.: AC3FI Times Cited: 0 Cited Reference Count: 8 Lorente, David Bianchini, Diletta Rodriguez-Vida, Alejo Omlin, Aurelius Pezaro, Carmel Ferraldeschi, Roberta Zivi, Andrea Attard, Gerhardt Chowdhury, Simon De Bono, Johann S. Elsevier sci ltd Oxford |
Uncontrolled Keywords: | cross-resistance |
Research teams: | ICR divisions > Cancer Therapeutics > Cancer Biomarkers ICR divisions > Clinical Studies > Cancer Biomarkers ICR divisions > Clinical Studies > Prostate Cancer Targeted Therapy Group |
Depositing User: | Alexander Smithson |
Date Deposited: | 04 Apr 2014 15:57 |
Last Modified: | 07 Jul 2017 15:48 |
URI: | http://publications.icr.ac.uk/id/eprint/13176 |
Actions (login required)
![]() |
View Item |